Hook & thesis
DocuSign (DOCU) feels mispriced to me right now. The market has punished the stock since the post-pandemic peak, but the company is profitable, generating roughly $1.12 billion in free cash flow, and is converting product momentum around its AI-powered Intelligent Agreement Management (IAM) into revenue. At a market cap near $11.84 billion and a price-to-sales of about 3.6, the stock looks like it should command a higher multiple if growth steadies and management continues buybacks.
My actionable stance: go long DOCU at $62.02 with a $53 stop and an $80 target, sizing for a medium-risk position. This is a long-term trade - expect to hold up to 180 trading days - but I will monitor mid-term catalysts and short-term technicals for adjustments.
What DocuSign does and why the market should care
DocuSign is primarily known for eSignature, but that label understates the strategic direction: the company is positioning itself as a workflow and contract lifecycle automation leader. Its product set includes eSignature, Contract Lifecycle Management (CLM), Document Generation, Notary, Web Forms and the newer Intelligent Agreement Management (IAM) suite that layers AI for drafting, extraction, and risk analysis.
Why investors should care: agreements are central to B2B commerce and legal workflows, and they create friction, cost and risk when handled manually. IAM promises to automate a portion of that workload and capture higher per-customer revenue through upsells from eSignature to full agreement automation. The legal AI and broader legal technology markets are forecast to expand materially over the coming years, which creates a large TAM tailwind if DocuSign continues to execute.
Numbers that matter
| Metric | Value |
|---|---|
| Current price | $62.02 |
| Market cap | $11.84B |
| Free cash flow (annual) | $1.12B |
| P/S | 3.6 |
| P/E | ~37.6 |
| EV/EBITDA | 16.8 |
| EPS (ttm) | $1.65 |
Those numbers point to a few useful observations. First, FCF of about $1.12 billion against an $11.8 billion market cap implies an FCF yield near 9-10% - not typical for a high-growth software name and attractive if growth continues. Second, valuation multiples such as EV/EBITDA of 16.8 and P/S 3.6 already embed a mixture of growth and margin expectations; the market appears unwilling to give DocuSign the multiple it enjoyed earlier in the cycle even though profitability and cash generation are real.
Recent trends & proof points
- Revenue traction: DocuSign reported Q2 2026 revenues of $830.2 million versus Box's $305.9 million in the same quarter, highlighting DocuSign's scale in agreement management and forms. Reported YoY revenue growth for DocuSign was about 9% in that period.
- Product mix shift: IAM is cited as representing roughly 12.6% of annual recurring revenue in recent commentary and the company has emphasized growing adoption.
- Profitability & buybacks: Management reported improved profitability metrics and record share repurchases in the quarter reported 06/05/2026, and raised full-year guidance. This combination of buybacks and positive FCF should lift EPS even with moderate top-line growth.
- Technicals: short-term momentum is constructive - the 10-day SMA ($60.94) sits below the current price, the 50-day SMA ($51.60) is comfortably lower, and RSI (~62) suggests room before overbought readings.
Valuation framing
At $62 the market cap is roughly $11.84 billion. Against last fiscal-year free cash flow of $1.12 billion the company trades at about 10x FCF, which is in-line with or cheaper than many profitable enterprise software peers that trade on higher revenue multiples but often lower cash conversion. Historically DocuSign commanded premium multiple during the pandemic surge, but that reflected a transition from growth-first to a more mature business. Today the valuation looks reasonable on cash-flow metrics and attractive if management sustains growth in higher-value offerings like IAM and continues buybacks.
There is room for multiple expansion if two things happen: 1) IAM adoption accelerates and becomes a larger percentage of ARR, increasing revenue growth and upsell economics, and 2) the market re-prices DocuSign closer to higher-growth software peers as investors reward durable FCF and higher gross margins from AI-enabled products.
Catalysts
- Quarterly results that show accelerating IAM revenue contribution and raised guidance - a repeat of the 06/05/2026 beat-and-raise would matter.
- Continued aggressive buybacks that materially reduce the share count and lift EPS.
- Product announcements or customer wins that demonstrate IAM materially reducing legal cycle times for large enterprises.
- Positive industry reports on legal AI adoption; an expanding TAM narrative from researchers (e.g., 07/07/2026 market forecasts) can change multiple expansion expectations.
Trade plan
Action: buy DOCU at $62.02 (current price). Entry is an exact limit at $62.02. Stop: $53.00. Target: $80.00.
Horizon: long term (180 trading days). Expect this to be a multi-quarter trade - the thesis relies on product adoption, buybacks and/or a re-rating that typically plays out over months. I will use a mid-term checkpoint at 45 trading days to reassess progress on revenue composition and buyback cadence, and a short-term checkpoint at 10 trading days to decide whether to trim or average depending on price action and volume.
Why these levels: the stop at $53 sits below the 50-day EMA (~$54.19) and near prior consolidation, offering protection against a technical breakdown while giving the trade room to breathe. The $80 target is conservative relative to the 52-week high of $86.65 and assumes a re-rating toward a higher P/S multiple driven by accelerating IAM contribution and margin expansion.
Risks and counterarguments
- Growth fatigue: revenue is growing in the high-single-digit range recently (about 9% YoY in Q2 2026). If top-line growth stays muted, multiples may compress further and offset FCF strength.
- AI overhang and execution risk: AI is a double-edged sword. Expectations on IAM are elevated; failure to deliver tangible time/cost savings for customers or to appropriately monetize the product could disappoint investors.
- Competition and pricing pressure: incumbents in legal tech and larger cloud suites could bundle similar capabilities, pressuring DocuSign's ability to upsell CLM or IAM at high margins.
- Multiple contraction: despite solid FCF, market sentiment around software multiples remains volatile. Macroeconomic tightening or sector rotation away from software could keep DocuSign stuck at current valuations.
- Short-term volatility: short interest and heavy intraday short volume have been significant on some days; this can cause abrupt price moves unrelated to fundamentals.
Counterargument: Critics would say the market has already priced in a more mature, slower-growth DocuSign and that current multiples are fair given lower revenue growth compared to hyper-growth peers. The fact that some analysts cut targets on 06/05/2026 despite a beat suggests sentiment is fragile: incremental beats may not move the stock if guidance is only in line with expectations.
What would change my mind
I will reassess the trade if one or more of the following occurs:
- Revenue growth stalls below low single digits sequentially and management reduces FY guidance - that would invalidate the growth re-rating case.
- Churn materially increases or enterprise upsell metrics deteriorate, suggesting IAM adoption is weaker than presented.
- Management stops buybacks or net share count is not reduced while margins deteriorate - that would reduce the EPS leverage thesis tied to buybacks and FCF conversion.
Conclusion
DocuSign is not a speculative, unprofitable cloud name. It generates real free cash flow, is profitable on an EPS basis, and has a plausible path to higher margins and revenue per customer via IAM. The market's current pricing embeds conservatism on growth and multiple expansion; that conservatism creates an actionable asymmetric trade with well-defined risk controls.
Buy at $62.02, stop at $53.00, and target $80.00 with a long-term horizon of 180 trading days. I expect catalysts over the next few quarters to either validate this call via accelerating IAM adoption and sustained buybacks or to force reconsideration if revenue and adoption metrics disappoint.
Key points
- DocuSign trades at an FCF yield near 9-10% with about $1.12B in free cash flow versus an $11.84B market cap.
- IAM represents early but growing contribution to ARR, estimated at ~12.6% and is the main growth lever.
- Actionable trade: long at $62.02, stop $53.00, target $80.00, horizon long term (180 trading days).
- Main risks: slower revenue growth, AI execution shortfall, competition, and multiple compression.